Желудочковые нарушения ритма. Желудочковая тахикардия и внезапная сердечная смерть: обзор руководства Европейского общества Кардиологов и Национальных рекомендаций 2022 года
https://doi.org/10.21626/XXXX-XXXX-2023-1-
Аннотация
В экскурсе нашей литературы представлены основополагающие положения рекомендаций Российского кардиологического общества (РКО) и руководство Европейского общества кардиологов (ЕОК) по эпидемиологии, диагностике, терапии и профилактики желудочковых нарушений ритма.
Список литературы
1. Литература
2. Рубрикатор клинических рекомендаций Министерства здравоохранения Российской Федерации. Национальные клинические рекомендации «Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть» 2020. [Электронный ресурс] / Рубрикатор клинических рекомендаций Министерства здравоохранения Российской Федерации. - Режим доступа: URL: https://cr.minzdrav.gov.ru/schema/569_1 (дата обращения 10.11.2022).
3. Zeppenfeld K. et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) //European Heart Journal. – 2022. – Т. 43. – №. 40. – С. 3997-4126.
4. Winkel B. G. et al. Nationwide study of sudden cardiac death in persons aged 1–35 years //European heart journal. – 2011. – Т. 32. – №. 8. – С. 983-990.
5. Аgesen F. N. et al. Temporal trends and sex differences in sudden cardiac death in the Copenhagen City heart study //Heart. – 2021. – Т. 107. – №. 16. – С. 1303-1309.
6. Myerburg R. J., Junttila M. J. Sudden cardiac death caused by coronary heart disease //Circulation. – 2012. – Т. 125. – №. 8. – С. 1043-1052.
7. Nakashima T. et al. Public-access defibrillation and neurological outcomes in patients with out-of-hospital cardiac arrest in Japan: a population-based cohort study //The Lancet. – 2019. – Т. 394. – №. 10216. – С. 2255-2262.
8. Patton K. K. et al. N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study //Heart rhythm. – 2011. – Т. 8. – №. 2. – С. 228-233.
9. Morici N. et al. Relevance of complete blood count parameters in the assessment of acute coronary syndromes: a combined hematological and cardiological perspective //Giornale Italiano di Cardiologia (2006). – 2019. – Т. 20. – №. 12. – С. 694-705.
10. Al-Khatib S. M. et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society //Journal of the American College of Cardiology. – 2018. – Т. 72. – №. 14. – С. e91-e220.
11. Garratt C. J. et al. Use of intravenous adenosine in sinus rhythm as a diagnostic test for latent preexcitation //The American journal of cardiology. – 1990. – Т. 65. – №. 13. – С. 868-873.
12. Ackerman M. J. et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) //Europace. – 2011. – Т. 13. – №. 8. – С. 1077-1109.
13. Bezzina C. R., Lahrouchi N., Priori S. G. Genetics of sudden cardiac death //Circulation research. – 2015. – Т. 116. – №. 12. – С. 1919-1936.
14. Myerburg R. J., Junttila M. J. Sudden cardiac death caused by coronary heart disease //Circulation. – 2012. – Т. 125. – №. 8. – С. 1043-1052.
15. Connolly S. J. et al. Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial //Jama. – 2006. – Т. 295. – №. 2. – С. 165-171.
16. Krahn A. D. et al. Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion //Circulation. – 2005. – Т. 112. – №. 15. – С. 2228-2234.
17. Penela D. et al. Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study //Journal of the American College of Cardiology. – 2013. – Т. 62. – №. 13. – С. 1195-1202.
18. Leren I. S. et al. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia //Heart Rhythm. – 2016. – Т. 13. – №. 2. – С. 433-440.
19. Nogami A. et al. Mapping and ablation of idiopathic ventricular fibrillation from the Purkinje system //Heart rhythm. – 2005. – Т. 2. – №. 6. – С. 646-649.
20. Betensky B. P., Marchlinski F. E. Outcomes of catheter ablation of ventricular tachycardia in the setting of structural heart disease //Current cardiology reports. – 2016. – Т. 18. – №. 7. – С. 1-10.
21. Nogami A. et al. Mapping and ablation of idiopathic ventricular fibrillation from the Purkinje system //Heart rhythm. – 2005. – Т. 2. – №. 6. – С. 646-649.
22. Kumar K. R. et al. Single coil implantable cardioverter defibrillator leads in patients with hypertrophic cardiomyopathy //The American journal of cardiology. – 2020. – Т. 125. – №. 12. – С. 1896-1900.
23. Ajijola O. A. et al. Bilateral cardiac sympathetic denervation for the management of electrical storm //Journal of the American College of Cardiology. – 2012. – Т. 59. – №. 1. – С. 91-92.
Рецензия
Для цитирования:
Шпадарева Е.Ф. Желудочковые нарушения ритма. Желудочковая тахикардия и внезапная сердечная смерть: обзор руководства Европейского общества Кардиологов и Национальных рекомендаций 2022 года. Опубликован 30 марта 2023. 2023;9(1). https://doi.org/10.21626/XXXX-XXXX-2023-1-
Просмотров: 139
Послать статью по эл. почте 